Clinical Trial Update: A First in Human Study of TT5 in Single and Multiple Ascending Doses in Healthy Volunteers and Surgical Patients [Phase 1]

View source ↗

Summary

Tafalgie Therapeutics is conducting a first-in-human Phase 1 study of TT5 with single and multiple ascending doses in healthy volunteers and surgical patients. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• TT5

Snippet

Sponsor: Tafalgie Therapeutics | Conditions: Pain | Phase 1 | Status: RECRUITING